Literature DB >> 31814916

LncRNA SNHG16 induced by TFAP2A modulates glycolysis and proliferation of endometrial carcinoma through miR-490-3p/HK2 axis.

Guangyu Zhang1, Anjun Ma2, Yuqin Jin3, Guoyou Pan3, Cong Wang3,4.   

Abstract

Increasing evidence indicates the important roles of long noncoding RNA (lncRNA) in the endometrial carcinoma (ECa). Here, we identified the roles of SNHG16 in the ECa proliferation and glycolysis, and revealed the underlying mechanism. Results presented that SNHG16 expression was increased in the ECa tissue and cells, and the ectopic SNHG16 overexpression was closely correlated with the poor survival rate and recurrence free survival of ECa. As regarding the upstream, transcription factor TFAP2A bound with the promotor region of SNHG16 and activated its transcription. In functional experiments, SNHG16 knockdown suppressed the proliferation, glycolysis and tumor growth of ECa cells. In mechanical experiments, SNHG16 upregulated HK2, the target gene of miR-490-3p, by competitively sponging miR-490-3p and then promoted endometrial carcinoma proliferation and glycolysis. In conclusion, this finding illustrates the vital role of SNHG16 via the TFAP2A/SNHG16/miR-490-3p/HK2 axis in the ECa proliferation and glycolysis, providing an interesting insight for the ECa tumorigenesis. AJTR
Copyright © 2019.

Entities:  

Keywords:  Endometrial carcinoma; HK2; SNHG16; glycolysis; miR-490-3p

Year:  2019        PMID: 31814916      PMCID: PMC6895515     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

1.  LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma.

Authors:  Shian Liao; Shuxing Xing; Yanhui Ma
Journal:  Cancer Chemother Pharmacol       Date:  2019-03-28       Impact factor: 3.333

Review 2.  Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment.

Authors:  Antonio Raffone; Antonio Travaglino; Gabriele Saccone; Anna Di Maio; Antonio Mollo; Massimo Mascolo; Rossella De Rosa; Giuseppe De Placido; Luigi Insabato; Fulvio Zullo
Journal:  Gynecol Endocrinol       Date:  2019-06-05       Impact factor: 2.260

3.  LncRNA CCAT1 negatively regulates miR-181a-5p to promote endometrial carcinoma cell proliferation and migration.

Authors:  Jing Yu; Lijuan Jiang; Yutao Gao; Qijian Sun; Beibei Liu; Yong Hu; Xuesong Han
Journal:  Exp Ther Med       Date:  2019-03-20       Impact factor: 2.447

Review 4.  SNHG20: A vital lncRNA in multiple human cancers.

Authors:  Wei Zhao; Xiaozhou Ma; Lina Liu; Qingyu Chen; Zihao Liu; Zheng Zhang; Shiqing Ma; Zhonghou Wang; Hongfa Li; Zuomin Wang; Jie Wu
Journal:  J Cell Physiol       Date:  2019-01-15       Impact factor: 6.384

5.  Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies.

Authors:  Madita Reutter; Günter Emons; Carsten Gründker
Journal:  Int J Gynecol Cancer       Date:  2013-01       Impact factor: 3.437

6.  Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.

Authors:  Qiuran Xu; Changwei Dou; Xin Liu; Liu Yang; Chao Ni; Jiahui Wang; Yang Guo; Wei Yang; Xiangmin Tong; Dongsheng Huang
Journal:  Biomed Pharmacother       Date:  2018-09-08       Impact factor: 6.529

7.  Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.

Authors:  Mitsutake Yano; Daisuke Shintani; Tomomi Katoh; Mei Hamada; Kozue Ito; Eito Kozawa; Kosei Hasegawa; Masanori Yasuda
Journal:  Diagn Pathol       Date:  2019-06-07       Impact factor: 2.644

8.  Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.

Authors:  Li Zhou; Ming Li; Xinyou Yu; Feng Gao; Wei Li
Journal:  Int J Biol Sci       Date:  2019-03-01       Impact factor: 6.580

9.  Differential Expression Patterns of Glycolytic Enzymes and Mitochondria-Dependent Apoptosis in PCOS Patients with Endometrial Hyperplasia, an Early Hallmark of Endometrial Cancer, In Vivo and the Impact of Metformin In Vitro.

Authors:  Tao Wang; Jiao Zhang; Min Hu; Yuehui Zhang; Peng Cui; Xin Li; Juan Li; Edvin Vestin; Mats Brännström; Linus R Shao; Håkan Billig
Journal:  Int J Biol Sci       Date:  2019-01-24       Impact factor: 6.580

10.  Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.

Authors:  Huihui Li; Yue Wang
Journal:  Med Sci Monit       Date:  2019-01-23
View more
  7 in total

1.  Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study.

Authors:  Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros
Journal:  Biomedicines       Date:  2022-06-04

2.  Human umbilical cord blood mesenchymal stem cells-derived exosomal microRNA-503-3p inhibits progression of human endometrial cancer cells through downregulating MEST.

Authors:  Ying Pan; Xue Wang; Yang Li; Peiyu Yan; Hong Zhang
Journal:  Cancer Gene Ther       Date:  2022-01-07       Impact factor: 5.854

3.  Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

Authors:  Shuangda Li; Yu Qi; Yiran Huang; Yanru Guo; Tong Huang; Li Jia
Journal:  J Physiol Biochem       Date:  2021-08-23       Impact factor: 4.158

Review 4.  LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers.

Authors:  Yuhang Xiao; Ta Xiao; Wei Ou; Zhining Wu; Jie Wu; Jinming Tang; Bo Tian; Yong Zhou; Min Su; Wenxiang Wang
Journal:  Biomark Res       Date:  2020-09-10

5.  LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p.

Authors:  Xiao Xiao; Ge Jiang; Shengtao Zhang; Shuo Hu; Yunshan Fan; Gang Li; Haiyang Yu; Shisheng He
Journal:  BMC Cancer       Date:  2021-04-06       Impact factor: 4.430

6.  Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities.

Authors:  Pouya Javadian; Chao Xu; Virginie Sjoelund; Lindsay E Borden; Justin Garland; Doris Mangiaracina Benbrook
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

Review 7.  MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?

Authors:  Yin Li; Dongmei Tian; Hao Chen; Yuanting Cai; Sang Chen; Shiwei Duan
Journal:  Oncol Lett       Date:  2021-07-22       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.